Работы, на которые ссылается эта работа

Работ: 55

Работа: Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra, Gitishree Das, Leonardo Fernandes Fraceto +9
Обзорная статья2018Цитирований: 11
ABI
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao +3
Обзорная статья2023Цитирований: 6
ABI
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management
S. Vincent Rajkumar
Статья2022Цитирований: 4
ABI
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model
Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung +12
Статья2021Цитирований: 3
ABI
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
Jianjun Chu, Youcai Deng, D.M. Benson +13
Статья2013Цитирований: 3
ABI
<i>In vivo</i> kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection
Yan Zhang, Diana L. Wallace, Catherine M. de Lara +8
Статья2007Цитирований: 3
ABI
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas, Roberto Salgado, Carsten Denkert +4
Обзорная статья2015Цитирований: 3
ABI
CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.
Joseph D. Malaer, Porunelloor A. Mathew
Статья2017Цитирований: 3
ABI
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie, Han Dong, Yong Liang +3
Обзорная статья2020Цитирований: 3
ABI
Bispecifics, trispecifics, and other novel immune treatments in myeloma
Guido Lancman, Joshua Richter, Ajai Chari
Обзорная статья2020Цитирований: 3
ABI
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Ying Gong, Roel G. J. Klein Wolterink, Jianxiang Wang +2
Обзорная статья2021Цитирований: 3
ABI
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan, Chao Wang, Jamie K. Teer +23
Статья2021Цитирований: 3
ABI
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Zhiwen Fu, Shijun Li, Sifei Han +2
Обзорная статья2022Цитирований: 3
ABI
Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
Feifei Li, Sheng Liu
Обзорная статья2022Цитирований: 3
ABI
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun, Haoyu Sun, Weihua Xiao +2
Обзорная статья2015Цитирований: 2
ABI
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun, Haoyu Sun, Cai Zhang +1
Обзорная статья2014Цитирований: 2
ABI
Are natural killer cells superior CAR drivers?
Hans Klingemann
Статья2014Цитирований: 2
ABI
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
Sagar Lonial, Jamie Cavenagh
Обзорная статья2009Цитирований: 2
ABI
Personalized Dendritic Cell-Based Tumor Immunotherapy
Nona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Обзорная статья2009Цитирований: 2
ABI
Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
Hua Jiang, Wenhao Zhang, Peipei Shang +10
Статья2013Цитирований: 2
ABI
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Loek J. Eggermont, Leonie E. Paulis, Jurjen Tel +1
Обзорная статья2014Цитирований: 2
ABI
Enhancement of Dendritic Cells as Vaccines for Cancer
Meghan E. Turnis, Cliona M. Rooney
Обзорная статья2010Цитирований: 2
ABI
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Marina Ratta, Francesco Fagnoni, Antonio Curti +9
Статья2002Цитирований: 2
ABI
Regulation of Dendritic Cell Migration to the Draining Lymph Node
Alfonso Martin‐Fontecha, Silvia Sebastiani, Uta E. Höpken +4
Статья2003Цитирований: 2
ABI
Targeting B-Cell Maturation Antigen in Multiple Myeloma
Yu‐Tzu Tai, Kenneth C. Anderson
Обзорная статья2015Цитирований: 2
ABI